243 related articles for article (PubMed ID: 24383676)
21. The efficacy and safety of Xuefu Zhuyu Decoction combined Mifepristone in the treatment of Uterine leiomyoma: A protocol systematic review and meta-analysis.
Shi S; Ye Q; Yu C; Peng F
Medicine (Baltimore); 2021 Jan; 100(3):e24306. PubMed ID: 33546059
[TBL] [Abstract][Full Text] [Related]
22. Add-on effect of the Guizhi Fuling formula for management of reduced fertility potential in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
Rong A; Ta N; E L; Meng W
Front Endocrinol (Lausanne); 2022; 13():995106. PubMed ID: 37143960
[TBL] [Abstract][Full Text] [Related]
23. [Effects and safety of varying doses of guizhi fuling capsule in patients with primary dysmenorrhea: a multi-center, randomized, double-blind, placebo-controlled clinical study].
Liu YJ; Xiao W; Wang ZZ; Zhao BJ; Zhou ZM; Jiang HZ; Jin Z; Wei SB; Wang Z; Wang DM; Xia QH; Lin J; Wang Q
Zhongguo Zhong Yao Za Zhi; 2013 Jun; 38(12):2019-22. PubMed ID: 24066604
[TBL] [Abstract][Full Text] [Related]
24. Guizhi Fuling Wan for uterine fibroids: A systematic review of in vivo studies.
Li M; Hung A; Yang AWH
J Ethnopharmacol; 2019 Dec; 245():112177. PubMed ID: 31445128
[TBL] [Abstract][Full Text] [Related]
25. Chinese herbal medicine for primary dysmenorrhoea.
Zhu X; Proctor M; Bensoussan A; Wu E; Smith CA
Cochrane Database Syst Rev; 2008 Apr; (2):CD005288. PubMed ID: 18425916
[TBL] [Abstract][Full Text] [Related]
26. Guizhi Fuling Capsule inhibits uterine fibroids growth by modulating Med12-mediated Wnt/β-Catenin signaling pathway.
Chen L; Chen H; Yang Q; Jiang Y; Liu L; Yu H; Chen Y; Li J; Chen N; Wang H; Wang Q
J Ethnopharmacol; 2022 May; 290():115115. PubMed ID: 35181487
[TBL] [Abstract][Full Text] [Related]
27. [Post-marketing surveillance on Guizhi Fuling Jiaonang based on literature review].
Wang GQ; Gao Y; Liu FM; Wei RL; Xie YM
Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(4):820-832. PubMed ID: 29600661
[TBL] [Abstract][Full Text] [Related]
28. [Mechanism Study on Danggui Shaoyao San and Guizhi Fuling Wan For Treating Primary Dysmenorrheal Based on Biological Network].
Wang YL; Ru SY; Fang Q; Li GQ; Pan YF; Yao Y; Xu F
Zhong Yao Cai; 2015 Nov; 38(11):2348-52. PubMed ID: 27356390
[TBL] [Abstract][Full Text] [Related]
29. Chinese herbal medicine for primary dysmenorrhoea.
Zhu X; Proctor M; Bensoussan A; Smith CA; Wu E
Cochrane Database Syst Rev; 2007 Oct; (4):CD005288. PubMed ID: 17943847
[TBL] [Abstract][Full Text] [Related]
30. Guizhi Fuling Formulation: A review on chemical constituents, quality control, pharmacokinetic studies, pharmacological properties, adverse reactions and clinical applications.
Liu X; Chen L; Sun P; Zhan Z; Wang J
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117277. PubMed ID: 37802375
[TBL] [Abstract][Full Text] [Related]
31. [Effect of Guizhi Fuling capsule and combination of active ingredients on rats with uterine myoma].
Heng QQ; Cao L; Li N; Ding G; Wang ZZ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2015 Jun; 40(11):2206-9. PubMed ID: 26552182
[TBL] [Abstract][Full Text] [Related]
32. Herbal medicine (Gyejibongneyong-hwan) for treating primary dysmenorrhoea: a protocol for a systematic review of randomised controlled trials.
Lee JA; Park S; Jung J; Jun JH; Choi J; Lee MS
BMJ Open; 2016 Sep; 6(9):e011071. PubMed ID: 27683510
[TBL] [Abstract][Full Text] [Related]
33. Oral traditional Chinese medication for adhesive small bowel obstruction.
Suo T; Gu X; Andersson R; Ma H; Zhang W; Deng W; Zhang B; Cai D; Qin X
Cochrane Database Syst Rev; 2012 May; (5):CD008836. PubMed ID: 22592734
[TBL] [Abstract][Full Text] [Related]
34. Comparison of effectiveness and safety between granules and decoction of Chinese herbal medicine: a systematic review of randomized clinical trials.
Luo H; Li Q; Flower A; Lewith G; Liu J
J Ethnopharmacol; 2012 Apr; 140(3):555-67. PubMed ID: 22343092
[TBL] [Abstract][Full Text] [Related]
35. Progesterone receptor modulators for endometriosis.
Fu J; Song H; Zhou M; Zhu H; Wang Y; Chen H; Huang W
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009881. PubMed ID: 28742263
[TBL] [Abstract][Full Text] [Related]
36. Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): A systematic review of randomised clinical trials.
Wang M; Guan X; Chi Y; Robinson N; Liu JP
Tuberculosis (Edinb); 2015 Jul; 95(4):364-72. PubMed ID: 25861717
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of GuiZhi-ShaoYao-ZhiMu Decoction for Treating Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Daily JW; Zhang T; Cao S; Park S
J Altern Complement Med; 2017 Oct; 23(10):756-770. PubMed ID: 28609129
[TBL] [Abstract][Full Text] [Related]
38. Chinese herbal medicine for endometriosis.
Flower A; Liu JP; Lewith G; Little P; Li Q
Cochrane Database Syst Rev; 2012 May; (5):CD006568. PubMed ID: 22592712
[TBL] [Abstract][Full Text] [Related]
39. Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction.
Sun L; Liu L; Zong S; Wang Z; Zhou J; Xu Z; Ding G; Xiao W; Kou J
J Ethnopharmacol; 2016 Sep; 191():273-279. PubMed ID: 27340106
[TBL] [Abstract][Full Text] [Related]
40. A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids.
Zeng L; Yang K; Liu H; Zhang G
Exp Ther Med; 2017 Nov; 14(5):4697-4710. PubMed ID: 29201170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
